المؤلفون: Shakura, V A, Titov, G A, Morozova, E A

المصدر: Journal of Physics: Conference Series ; volume 2697, issue 1, page 012072 ; ISSN 1742-6588 1742-6596

الاتاحة: http://dx.doi.org/10.1088/1742-6596/2697/1/012072
https://iopscience.iop.org/article/10.1088/1742-6596/2697/1/012072
https://iopscience.iop.org/article/10.1088/1742-6596/2697/1/012072/pdf

المؤلفون: Karpachevsky, A M, Titov, G S

المصدر: IOP Conference Series: Earth and Environmental Science ; volume 1154, issue 1, page 012051 ; ISSN 1755-1307 1755-1315

الاتاحة: http://dx.doi.org/10.1088/1755-1315/1154/1/012051
https://iopscience.iop.org/article/10.1088/1755-1315/1154/1/012051
https://iopscience.iop.org/article/10.1088/1755-1315/1154/1/012051/pdf

المؤلفون: Титов, Г. Н., Тимофеева, В. В., Titov, G. N., Timofeeva, V. V.

مصطلحات موضوعية: PARTIALLY ORDERED SET, LATTICE, MAXIMUM TRAIL LENGTH, STEP OF SEMI-MODULAR LATTICE, ЧАСТИЧНО УПОРЯДОЧЕННОЕ МНОЖЕСТВО, РЕШЁТКА, ДЛИНА МАКСИМАЛЬНОЙ ЦЕПИ, СТУПЕНЬ ПОЛУМОДУЛЯРНОСТИ РЕШЁТКИ

وصف الملف: application/pdf

Relation: Наука. Информатизация. Технологии. Образование : материалы XIII международной научно-практической конференции. - Екатеринбург, 2020; Титов, Г. Н. Алгоритм нахождения ступеней полумодулярности конечной решётки / Г. Н. Титов, В. В. Тимофеева, // Наука. Информатизация. Технологии. Образование : материалы XIII международной научно-практической конференции, г. Екатеринбург, 24-28 февраля 2020 г. - Екатеринбург : Издательство РГППУ, 2020. - С. 389-402.; https://elar.rsvpu.ru/handle/123456789/31385

الاتاحة: https://elar.rsvpu.ru/handle/123456789/31385

المؤلفون: Тимофеева, В. В., Титов, Г. Н., Timofeeva, V. V., Titov, G. N.

مصطلحات موضوعية: MATHEMATICAL PUZZLES, PROGRAM, REBUSSUM, REBUSROOT, МАТЕМАТИЧЕСКИЕ РЕБУСЫ, ПРОГРАММА, РЕБУС-СУММА, РЕБУС-КОРЕНЬ

جغرافية الموضوع: RU, RSVPU, РФ, РГППУ

وصف الملف: application/pdf

Relation: Наука. Информатизация. Технологии. Образование : материалы XII международной научно-практической конференции. - Екатеринбург, 2019; Тимофеева, В. В. О компьютерном решении математических ребусов для школьников 5–8 классов / В. В. Тимофеева, Г. Н. Титов // Наука. Информатизация. Технологии. Образование : материалы XII международной научно-практической конференции, г. Екатеринбург, 25 февраля - 1 марта 2019 г. - Екатеринбург : Издательство РГППУ, 2019. - С. 687-692.; https://elar.rsvpu.ru/handle/123456789/28328

الاتاحة: https://elar.rsvpu.ru/handle/123456789/28328

المؤلفون: Shakura, V A, Titov, G A, Morozova, E A

المصدر: Journal of Physics: Conference Series; Dec2023, Vol. 2697 Issue 1, p1-6, 6p

المؤلفون: Puring, S M, Vatuzov, D N, Tyurin, N P, Titov, G I

المصدر: IOP Conference Series: Materials Science and Engineering ; volume 698, issue 5, page 055029 ; ISSN 1757-8981 1757-899X

الاتاحة: http://dx.doi.org/10.1088/1757-899x/698/5/055029
https://iopscience.iop.org/article/10.1088/1757-899X/698/5/055029/pdf
https://iopscience.iop.org/article/10.1088/1757-899X/698/5/055029

المؤلفون: Titov, G. I., Tomareva-Patlakhova, V. V., Voloshin, V. A., Zukow, W., Gozhenko, O. A.

المصدر: Journal of Education, Health and Sport; Tom 8 Nr 12 (2018); 1001-1012 ; Journal of Education, Health and Sport; Vol. 8 No. 12 (2018); 1001-1012 ; 2391-8306

مصطلحات موضوعية: resort medical center, quality management system

وصف الملف: application/pdf

Relation: https://apcz.umk.pl/JEHS/article/view/6947/pdf; https://apcz.umk.pl/JEHS/article/view/6947

الاتاحة: https://apcz.umk.pl/JEHS/article/view/6947

المؤلفون: O. Koroleva A., L. Kogoniya M., M. Byakhova M., A. Titov G., О. Королева А., Л. Когония М., М. Бяхова М., А. Титов Г.

المصدر: Malignant tumours; Том 8, № 2 (2018); 64-75 ; Злокачественные опухоли; Том 8, № 2 (2018); 64-75 ; 2587-6813 ; 2224-5057

مصطلحات موضوعية: stomach cancer, chemotherapy, complex geriatric evaluation, adjuvant therapy, palliative therapy, рак желудка, химиотерапия, комплексная гериатрическая оценка, адъювантная терапия, паллиативная терапия

وصف الملف: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/518/372; Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015. Vol. 136. P. E359–86.; GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Lyon, France: International Agency for Research on Cancer, 2013. Available from: http://globocan.iarc.fr.; Parkin D. M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer. 2006. Vol. 118. P. 3030–3044.; Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 2014. Vol. 64. P. 9–29.; Статистика злокачественных новообразований в России и странах СНГ в 2013 г. / под ред. Давыдова М. И., Аксель Е. М. Москва, 2015.; Glimelius B., Ekstrom K., Hoffman K., Graf W., Sjoden P. O., Haglund U. et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann. Oncol. 1997. Vol. 8. P. 163–168.; Pyrhonen S., Kuitunen T., Nyandoto P., Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br. J. Cancer. 1995. Vol. 71. P. 587–591.; Murad A. M., Santiago F. F., Petroianu A., Rocha P. R., Rodrigues M. A., Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer. 1993. Vol. 72. P. 37–41.; Polee M. B., Hop W. C., Kok T. C., Eskens F. A., van der Burg M. E., Splinter T. A. et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br. J. Cancer. 2003. Vol. 89. P. 2045–2050.; Chau I., Norman A. R., Cunningham D., Waters J. S., Oates J., Ross P. J. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J. Clin. Oncol. 2004. Vol. 22. P. 2395–2403.; Trumper M., Ross P. J., Cunningham D., Norman A. R., Hawkins R., Seymour M. et al. Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials. Eur. J. Cancer. 2006. Vol. 42. P. 827–834.; Jatoi A., Foster N. R., Egner J. R., Burch P. A., Stella P. J., Rubin J. et al. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int. J. Oncol. 2010. Vol. 36. P. 601–606.; Hurria A., Lichtman S. M. Clinical pharmacology of cancer therapies in older adults. Br. J. Cancer. 2008. Vol. 98. P. 517–522.; Repetto L., Fratino L., Audisio R. A., Venturino A., Gianni W., Vercelli M. et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J. Clin. Oncol. 2002. Vol. 20. P. 494–502.; Wedding U., Kodding D., Pientka L., Steinmetz H. T., Schmitz S. Physicians’ judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit. Rev. Oncol. Hematol. 2007. Vol. 64. P. 1–9.; Extermann M., Aapro M., Bernabei R., Cohen H. J., Droz J. P., Lichtman S. et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit. Rev. Oncol. Hematol. 2005. Vol. 55. P. 241–252.; Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J. Clin. Oncol. 2007. Vol. 25. P. 1824–1831.; Pal S. K., Katheria V., Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J. Clin. 2010. Vol. 60. P. 120–132.; Rodin M. B., Mohile S. G. A practical approach to geriatric assessment in oncology. J. Clin. Oncol. 2007. Vol. 25. P. 1936–1944.; Hurria A., Gupta S., Zauderer M., Zuckerman E. L., Cohen H. J., Muss H. et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005. Vol. 104. P. 1998–2005.; Hurria A., Cirrincione C. T., Muss H. B., Kornblith A. B., Barry W., Artz A. S. et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J. Clin. Oncol. 2011. Vol. 29. P. 1290–1296.; Hurria A., Togawa K., Mohile S. G., Owusu C., Klepin H. D., Gross C. P. et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J. Clin. Oncol. 2011. Vol. 29. P. 3457–3465.; Cunningham D., Allum W. H., Stenning S. P., Thompson J. N., Van de Velde C. J., Nicolson M. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 2006. Vol. 355. P. 11–20.; Ychou M., Boige V., Pignon J. P., Conroy T., Bouche O., Lebreton G. et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J. Clin. Oncol. 2011. Vol. 29. P. 1715–1721.; Xiong B. H., Cheng Y., Ma L., Zhang C. Q. An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer. Cancer Invest. 2014. Vol. 32. P. 272–284.; Kulig J., Kolodziejczyk P., Sierzega M., Bobrzynski L., Jedrys J., Popiela T. et al. Adjuvant chemotherapy with etoposide, adriamycin and cisplatin compared with surgery alone in the treatment of gastric cancer: a phase III randomized, multicenter, clinical trial. Oncology. 2010. Vol. 78. P. 54–61.; Bouche O., Ychou M., Burtin P., Bedenne L., Ducreux M., Lebreton G. et al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann. Oncol. 2005. Vol. 16. P. 1488–1497.; Sakuramoto S., Sasako M., Yamaguchi T., Kinoshita T., Fujii M., Nashimoto A. et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N. Engl. J. Med. 2007. Vol. 357. P. 1810–1820.; Bang Y. J., Kim Y. W., Yang H. K., Chung H. C., Park Y. K., Lee K. H. et al. CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012. Vol. 379. P. 315–321.; Sasako M., Sakuramoto S., Katai H., Kinoshita T., Furukawa H., Yamaguchi T. et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J. Clin. Oncol. 2011. Vol. 29. P. 4387–4393.; Noh S. H., Park S. R., Yang H. K., Chung H. C., Chung I. J., Kim S. W. et al. CLASSIC trial investigators. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomized phase 3 trial. Lancet Oncol. 2014. Vol. 15. P. 1389–1396.; Wagner A. D., Unverzagt S., Grothe W., Kleber G., Grothey A., Haerting J., Fleig W. E. Chemotherapy for advanced gastric cancer. Cochrane Database Syst. Rev. 2010. CD004064.; Webb A., Cunningham D., Scarffe J. H., Harper P., Norman A., Joffe J. K. et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J. Clin. Oncol. 1997. Vol. 5. P. 261–267.; Kim N. K., Park Y. S., Heo D. S., Suh C., Kim S. Y., Park K. C. et al. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer. 1993. Vol. 71. P. 3813–3818.; Ohtsu A., Shimada Y., Shirao K., Boku N., Hyodo I., Saito H. et al. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205). J. Clin. Oncol. 2003. Vol. 21. P. 54–59.; Lord S. R., Hall P. S., McShane P., Brown J., Seymour M. T. Factors predicting outcome for advanced gastroesophageal cancer in elderly patients receiving palliative chemotherapy. Clin. Oncol. 2010. Vol. 22. P. 107–113.; Cunningham D., Starling N., Rao S., Iveson T., Nicolson M., Coxon F. et al. Upper Gastrointestinal Clinical Studies Group of the National Cancer Research Institute of the United Kingdom. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N. Engl. J. Med. 2008. Vol. 358. P. 36–46.; Al-Batran S. E., Hartmann J. T., Probst S., Schmalenberg H., Hollerbach S., Hofheinz R. et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J. Clin. Oncol. 2008. Vol. 26. P. 1435–1442.; Santini D., Graziano F., Catalano V., Di Seri M., Testa E., Baldelli A. M. et al. Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. BMC Cancer. 2006. Vol. 6. P. 125–131.; Choi I. S., Oh D. Y., Kim B. S., Lee K. W., Kim J. H., Lee J. S. Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer. Cancer Res. Treat. 2007. Vol. 39. P. 99–103.; Liu Z. F., Guo Q. S., Zhang X. Q., Yang X. G., Guan F., Fu Z., Wang M. Y. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer. Am. J. Clin. Oncol. 2008. Vol. 31. P. 259–263.; Dong N., Jiang W., Li H., Liu Z., Xu X., Wang M. Triweekly oxaliplatin plus oral capecitabine as first-line chemotherapy in elderly patients with advanced gastric cancer. Am. J. Clin. Oncol. 2009. Vol. 32. P. 559–563.; Zhao J. G., Qiu F., Xiong J. P., Zhang L., Xiang X. J., Yu F. et al. A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer. Anticancer Drugs. 2009. Vol. 20. P. 281–286.; Xiang X. J., Zhang L., Qiu F., Yu F., Zhan Z. Y., Feng M. et al. A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer. Chemotherapy. 2012. Vol. 58. P. 1–7.; Catalano V., Bisonni R., Graziano F., Giordani P., Alessandroni P., Baldelli A. M. et al. A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer. 2013. Vol. 16. P. 411–419.; Nardi M., Azzarello D., Maisano R., Del Medico P., Giannicola R., Raffaele M. et al. FOLFOX-4 regimen as fist-line chemotherapy in elderly patients with advanced gastric cancer: a safety study. J. Chemother. 2007. Vol. 19. P. 85–89.; Kim H. S., Kim J. H., Kim H. J., Jang H. J., Kim J. B., Kim J. W. et al. Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status. Oncol. Lett. 2012. Vol. 3. P. 425–428.; Cho Y. H., Kim S. Y., Hong Lee M., Yoo M. W., Bang H. Y., Lee K. Y., Yoon S. Y. Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil / leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer. Gastric Cancer. 2012. Vol. 15. P. 389–395.; Al-Batran S. E., Pauligk C., Homann N., Hartmann J. T., Moehler M., Probst S. et al. The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+). Eur. J. Cancer. 2013. Vol. 49. P. 835–842.; Kang Y. K., Kang W. K., Shin D. B., Chen J., Xiong J., Wang J. et al. Capecitabine / cisplatin versus 5-fluorouracil / cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann. Oncol. 2009. Vol. 20. P. 666–673.; Okines A. F., Norman A. R., McCloud P., Kang Y. K., Cunningham D. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann. Oncol. 2009. Vol. 20. P. 1529–1534.; Boku N., Yamamoto S., Fukuda H., Shirao K., Doi T., Sawaki A. et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol. 2009. Vol. 10. P. 1063–1069.; Ajani J. A., Rodriguez W., Bodoky G., Moiseyenko V., Lichinitser M., Gorbunova V. et al. Multicenter phase III comparison of cisplatin / S-1 with cisplatin / infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J. Clin. Oncol. 2010. Vol. 28. P. 1547–1553.; Lee J. L., Kang Y. K., Kang H. J., Lee K. H., Zang D. Y., Ryoo B. Y. et al. A randomized multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br. J. Cancer. 2008. Vol. 99. P. 584–590; Hwang I. G., Lee H. R., Lee H. Y., Ji J. H., Kang J. H., Lee S. I. et al. First-line capecitabine (X) monotherapy versus capecitabine plus oxaliplatin (XELOX) in elderly patients with advanced gastric cancer (AGC): results from the first interim analysis. J. Clin. Oncol. 2015. Vol. 33 (suppl). abstr4051.; Koizumi W., Akiya T., Sato A., Sakuyama T., Sasaki E., Tomidokoro T. et al. Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study. Cancer Chemother. Pharmacol. 2010. Vol. 65. P. 1093–1099.; Petrioli R., Pascucci A., Francini E., Marsili S., Fiaschi A. I., Civitelli S. et al. Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors. Anticancer Drugs. 2008. Vol. 19. P. 91–96.; Bang Y. J., Van Cutsem E., Feyereislova A., Chung H. C., Shen L., Sawaki A. et al. ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. Lancet. 2010. Vol. 376. P. 687–697.; Fuchs C. S., Tomasek J., Yong C. J., Dumitru F., Passalacqua R., Goswami C. et al. Ramucirumab monotherapy for previously treated advanced gastric or gastrooesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebocontrolled, phase 3 trial. Lancet. 2014. Vol. 383. P. 31–39.; Wilke H., Muro K., Van Cutsem E., Oh S. C., Bodoky G., Shimada Y. et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014. Vol. 15. P. 1224–1235.; Van Cutsem E., Moiseyenko V. M., Tjulandin S. et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J. Clin. Oncol. 2006. Vol. 24. P. 4991–4997.; Ajani J. A., Moiseyenko V. M., Tjulandin S. et al. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group. J. Clin. Oncol. 2007. Vol. 25. P. 3210–3216.; Ilson D. H. Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime? J. Clin. Oncol. 2007. Vol. 25 (22). P. 3188–3190.; Cunningham D., Starling N., Rao S. et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N. Engl. J. Med. 2008. Vol. 358 (1). P. 36–46.; https://www.malignanttumors.org/jour/article/view/518

الاتاحة: https://www.malignanttumors.org/jour/article/view/518
https://doi.org/10.18027/2224-5057-2018-8-2-64-75

المؤلفون: D. Zhebrun A., A. Maslyansky L., A. Titov G., A. Patrukhin P., A. Kostareva A., I. Goltseva S., N. Arsentyeva A., N. Lyubimova E., A. Totolyan A., Д. Жебрун А., А. Маслянский Л., А. Титов Г., А. Патрухин П., А. Костарева А., И. Гольцева С., Н. Арсентьева А., Н. Любимова E., А. Тотолян А.

المصدر: Rheumatology Science and Practice; Vol 53, No 1 (2015); 58-62 ; Научно-практическая ревматология; Vol 53, No 1 (2015); 58-62 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20151

مصطلحات موضوعية: rheumatoid arthritis, chemokines, synovial fluid, DAS28, angiogenesis, ревматоидный артрит, хемокины, синовиальная жидкость, ангиогенез

وصف الملف: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2039/1285; Gabriel S, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009 May 19;11(3):229. DOI:10.1186/ar2669; Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. J Clin Rheumatol. 2005;11(3 Suppl):39–44. DOI:10.1097/01.rhu.0000166673.34461.33; Szekanecz Z, Vegvari A, Szabo Z, Koch A. Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed). 2010 Jan 1; 2:153–67. DOI:10.2741/s53; Жебрун ДА, Маслянский АЛ, Титов АГ и др. Содержание некоторых хемокинов в нормальной синовиальной жидкости. Медицинская иммунология. 2014;16(2):189–94 [Zhebrun DA, Maslyanskiy AL, Titov AG, et al. Angiogenic and angiostatic chemokines level in normal synovial fluid. Meditsinskaya immunologiya = Medical Immunology. 2014;16(2):189–94 (In Russ.)].; Насонов ЕЛ, Насонова ВА. Ревматология: национальное руководство. Москва: ГЭОТАР-Медиа; 2008 [Nasonov EL, Nasonova VA, editors. Revmatologiya. Natsional’noe rukovodstvo [Rheumatology. National Guide]. Moscow: GEOTAR-media; 2008].; Жебрун ДА, Маслянский АЛ, Титов АГ и др. Определение мРНК ангиогенных и ангиостатических хемокинов и их рецепторов в синовиальной оболочке методом количественной ПЦП в реальном времени. Медицинская иммунология. 2013,15(6):525–36 [Zhebrun DA, Maslyansky AL, Titov AG, et al. Analysis of expression of angiogenic and angiostatic chemokines and their receptors in synovial tissue by quantitative real-time PCR. Meditsinskaya immunologiya = Medical Immunology. 2013;15(6):525–36 (In Russ.)].; Hampel U, Sesselmann S, Iserovich P, et al. Chemokine and cytokine levels in osteoarthritis and rheumatoid arthritis synovial fluid. J Immunol Methods. 2013 Oct 31;396(1–2):134–9. DOI:10.1016/j.jim.2013.08.007; Endres M, Andreas K, Kalwitz G, et al. Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage. 2010 Nov;18(11):1458–66. DOI:10.1016/j.joca.2010.08.003; McNearney T, Baethge BA, Cao S, et al. Excitatory amino acids, TNFa, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol. 2004 Sep;137(3):621–7. DOI:10.1111/j.1365-2249.2004.02563.x; Ueno A, Yamamura M, Iwahashi M, et al. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis. Rheumatol Int. 2005 Jun;25(5):361–7. DOI:10.1007/s00296-004-0449-x; Pickens SR, Chamberlain ND, Volin MV, et al. Characterization of CCL19 and CCL21 in rheumatoid arthritis. Arthritis Rheum. 2011 Apr;63(4):914–22. DOI:10.1002/art.30232; Stanczyk J, Kowalski M, Grzegorczyk J, et al. RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Mediators Inflamm. 2005 Dec 14;2005(6):343–8. DOI:10.1155/MI.2005.343; Жебрун ДА, Тотолян Арег А, Маслянский АЛ и др. Синтез ангиогенных и ангиостатических СXС-хемокинов и их рецепторов в синовиальной оболочке при ревматоидном артрите. Цитокины и воспаление. 2014;(2)39–44 [Zhebrun DA, Totolian Areg A, Maslyanskiy AL, et al. Synthesis of angiogenic and angiostatic СXС chemokines and their receptors in synovial tissue of patients with rheumatoid arthritis. Tsitokiny i vospalenie. 2014;(2)39–44 (In Russ.)].; Жебрун ДА, Тотолян Арег А, Маслянский АЛ и др. Синтез некоторых СС-хемокинов и их рецепторов в синовиальной оболочке при ревматоидном артрите. Бюллетень экспериментальной биологии и медицины. 2014;158(8):153–8 [Zhebrun DA, Totolyan Areg A, Maslyanskii AL, et al. The synthesis of certain CC-chemokines and their receptors in synovium in rheumatoid arthritis. Byulleten' eksperimental'noi biologii i meditsiny. 2014;158(8):153–8 (In Russ.)].; Kuan WP, Tam LS, Wong CK, et al. CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol. 2010 Feb;37(2):257–64. DOI:10.3899/jrheum.090769; Airoldi I, Ribatti D. Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors. J Leukoc Biol. 2011 Nov;90(5):875–82. DOI:10.1189/jlb.0511237; Schmutz C, Hulme A, Burman A, et al. Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5. Arthritis Res Ther. 2005;7(2):R217–29. DOI:10.1186/ar1475; Ellingsen T, Buus A, Stengaard-Pedersen K. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis. J Rheumatol. 2001;28(1):41–6.; Stankovic A, Slavic V, Stamenkovic B, et al. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity. Bratisl Lek Listy. 2009;110(10):641–6.; Hitchon CA, Alex P, Erdile L, et al. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol. 2004;31(12):2336–46.; https://rsp.mediar-press.net/rsp/article/view/2039

الاتاحة: https://rsp.mediar-press.net/rsp/article/view/2039
https://doi.org/10.14412/1995-4484-2015-58-62

Alternate Title: Радіоізотопна оцінка стану репаративного остеогенезу при різних формах остеомієліту нижньої щелепи. (Ukrainian)

المؤلفون: Komskyi, M. P., G Romanenko, Ye., Lisova, I. G., Titov, G. I., Trushenko, O. S., Lavreniuk, Ya. V.

المصدر: Medical Perspectives / Medičnì Perspektivi; 2023, Issue 1, p141-147, 7p

مصطلحات موضوعية: OSTEOMYELITIS, BONE growth, MANDIBLE, SCINTILLATION cameras, INTRAVENOUS injections, BLOOD flow

المؤلفون: Nguyen, T. K., Titov, G. D., Kinzhalov, M. A., Rostovskii, N. V.

مصطلحات موضوعية: VINYL AZIDES, PHOTOCATALYSIS, PYRIMIDINE

وصف الملف: application/pdf

Relation: info:eu-repo/grantAgreement/RSF//19-73-10090; Актуальные вопросы органической химии и биотехнологии. — Екатеринбург, 2020; Vinyl azide strategy for the synthesis of tetrasubstituted pyrimidines / T. K. Nguyen, G. D. Titov, M. A. Kinzhalov, N. V. Rostovskii // Актуальные вопросы органической химии и биотехнологии : материалы очных докладов международной научной конференции (Екатеринбург, 18–21 ноября 2020 г.). — Екатеринбург : Издательство АМБ, 2020. — С. 184-185.; http://elar.urfu.ru/handle/10995/96941

الاتاحة: http://elar.urfu.ru/handle/10995/96941

المؤلفون: Somov, Ye., Butyrin, S., Titov, G., Yakimov, Ye.

المصدر: IFAC Proceedings Volumes ; volume 40, issue 7, page 515-520 ; ISSN 1474-6670

الاتاحة: http://dx.doi.org/10.3182/20070625-5-fr-2916.00088
https://api.elsevier.com/content/article/PII:S1474667015332948?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1474667015332948?httpAccept=text/plain

المؤلفون: Titov, G. N., Timofeeva, V. V.

مصطلحات موضوعية: LATTICE, MAXIMUM TRAIL LENGTH, PARTIALLY ORDERED SET, РЕШЁТКА, STEP OF SEMI-MODULAR LATTICE, ЧАСТИЧНО УПОРЯДОЧЕННОЕ МНОЖЕСТВО, ДЛИНА МАКСИМАЛЬНОЙ ЦЕПИ, СТУПЕНЬ ПОЛУМОДУЛЯРНОСТИ РЕШЁТКИ

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3377::a434e9cc52a15e4fd9b757e75a6168b8
https://elar.rsvpu.ru/handle/123456789/31385

Additional Titles: ALGORITHM FOR FINDING STEPS OF SEMI-MODULAR FINITE LATTICE

المؤلفون: Титов, Г. Н., Тимофеева, В. В., Titov, G. N., Timofeeva, V. V.

مصطلحات الفهرس: PARTIALLY ORDERED SET, LATTICE, MAXIMUM TRAIL LENGTH, STEP OF SEMI-MODULAR LATTICE, ЧАСТИЧНО УПОРЯДОЧЕННОЕ МНОЖЕСТВО, РЕШЁТКА, ДЛИНА МАКСИМАЛЬНОЙ ЦЕПИ, СТУПЕНЬ ПОЛУМОДУЛЯРНОСТИ РЕШЁТКИ, Conference Paper, info:eu-repo/semantics/conferenceObject, info:eu-repo/semantics/publishedVersion

URL: Наука. Информатизация. Технологии. Образование : материалы XIII международной научно-практической конференции. - Екатеринбург, 2020

المؤلفون: Timofeeva, V. V., Titov, G. N.

مصطلحات موضوعية: REBUSSUM, ПРОГРАММА, PROGRAM, МАТЕМАТИЧЕСКИЕ РЕБУСЫ, REBUSROOT, РЕБУС-СУММА, РЕБУС-КОРЕНЬ, MATHEMATICAL PUZZLES

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3377::efa3172164bac4be64b0d66cbeffbb0c
https://elar.rsvpu.ru/handle/123456789/28328

المؤلفون: Somov, Ye., Butyrin, S., Somov, S., Somova, T., Testoyedov, N., Rayevsky, V., Titov, G., Yakimov, Ye., Ovchinnikov, A., Mathylenko, M.

المصدر: AIP Conference Proceedings ; volume 1798, page 020148 ; ISSN 0094-243X

الاتاحة: http://dx.doi.org/10.1063/1.4972740

Additional Titles: About computer solution of mathematical puzzles for pupils 5–8 classes

المؤلفون: Тимофеева, В. В., Титов, Г. Н., Timofeeva, V. V., Titov, G. N.

مصطلحات الفهرس: MATHEMATICAL PUZZLES, PROGRAM, REBUSSUM, REBUSROOT, МАТЕМАТИЧЕСКИЕ РЕБУСЫ, ПРОГРАММА, РЕБУС-СУММА, РЕБУС-КОРЕНЬ, Conference Paper, info:eu-repo/semantics/conferenceObject, info:eu-repo/semantics/publishedVersion

URL: Наука. Информатизация. Технологии. Образование : материалы XII международной научно-практической конференции. - Екатеринбург, 2019

المؤلفون: Salkov, M., Tsymbaliuk, V., Dzyak, L., Rodinsky, A., Cherednichenko, Y., Titov, G.

مصطلحات موضوعية: Neurosurgery

وصف الملف: text

Relation: http://repo.dma.dp.ua/1453/1/EurSpineJ%202016.pdf; Salkov, M. and Tsymbaliuk, V. and Dzyak, L. and Rodinsky, A. and Cherednichenko, Y. and Titov, G. (2016) New concept of pathogenesis of impaired circulation in traumatic cervical spinal cord injury and its impact on disease severity: case series of four patients. Eur Spine J, Vol.25 (Supp 1). pp. 11-18. ISSN 0940-6719, eISSN 1432-0932

الاتاحة: http://repo.dma.dp.ua/1453/
http://repo.dma.dp.ua/1453/1/EurSpineJ%202016.pdf
https://doi.org/10.1007/s00586-015-4015-x

المؤلفون: Tashlykov, O. L., Shcheklein, S. E., Titov, G. P., Nosov, D. A., Tuchkov, A. M.

المصدر: Izvestiya Wysshikh Uchebnykh Zawedeniy, Yadernaya Energetika

مصطلحات موضوعية: ANALYTICAL SIMULATOR, ComputerApplications_COMPUTERSINOTHERSYSTEMS, PERSONNEL TRAINING, NUCLEAR POWER INDUSTRY, NUCLEAR POWER SYSTEM, FAST NEUTRON REACTOR

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______917::8905463939e15cdc302997b11d61dad4
https://hdl.handle.net/10995/90482

المؤلفون: Somov, Ye., Rayevsky, V., Titov, G., Yakimov, Ye., Mathylenko, M.

المصدر: IFAC-PapersOnLine ; volume 48, issue 9, page 210-215 ; ISSN 2405-8963

الاتاحة: http://dx.doi.org/10.1016/j.ifacol.2015.08.085
https://api.elsevier.com/content/article/PII:S2405896315009520?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S2405896315009520?httpAccept=text/plain